Human platelet alloantigen typing: PCR analysis is not a substitute for serological methods
- 1 March 1994
- journal article
- Published by Wiley in Transfusion Medicine
- Vol. 4 (1) , 9-14
- https://doi.org/10.1111/j.1365-3148.1994.tb00237.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel.Proceedings of the National Academy of Sciences, 1991
- Typing of fetal platelet alloantigens when platelets are not availableThe Lancet, 1990
- Polymorphism of human platelet membrane glycoprotein IIb associated with the Baka/Bakb alloantigen systemBlood, 1990
- Organization of the gene for platelet glycoprotein IIbBiochemistry, 1990
- The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.Journal of Clinical Investigation, 1989
- Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodiesBlood, 1987
- Immunochemical characterization of the platelet-specific alloantigen Leka: a comparative study with the PlA1 alloantigenBlood, 1984
- Isolation and immunologic characterization of the human platelet alloantigen, P1A1Molecular Immunology, 1979
- An Abnormal Platelet Glycoprotein Pattern in Three Cases of Glanzmann's ThrombastheniaBritish Journal of Haematology, 1974
- Congenital bleeding disorders with long bleeding time and normal platelet countThe American Journal of Medicine, 1966